Patient-derived stem cells could improve drug research for Parkinson's

Researchers have taken a step toward better drug therapies for Parkinson's disease and Huntington's disease by investigating signs of distress and vulnerability in patient-derived cells. Cells derived from patients with Parkinson's had different responses to drug treatments depending on the type of Parkinson's each patient had. These are the latest advances from the NINDS iPS cell consortia.

Source: http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_nih_stem_cells.htm

Amanda Righetti Amanda Swisten Amber Arbucci Amber Brkich Amber Heard